trial · primary record
Multiple sarcoma-specific CAR-T cells and sarcoma vaccines
Sarcoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Safety of CART cells infusion |
| Registry ID | NCT04433221 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:40.334Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04433221
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.